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ABSTRACT
The study of eukaryotic gene transcription depends
on methods to discover distal cis-acting control
sequences. Comparative bioinformatics is one pow-
erful strategy to reveal these domains, but still
requiresconventionalwet-benchtechniquestoeluci-
datetheirspecificityandfunction.TheDNaseIhyper-
sensitivity assay (DHA) is also a method to identify
regulatory domains, but can also suggest their
function. Technically however, the classical DHA is
constrainedtomappinggenelociinsmallincrements
of  20 kb. This limitation hinders efficient and
comprehensive analysis of distal gene regions.
Here, we report an improved method termed mega-
DHA that extends the range of existing DHAs to
facilitate assaying intervals that approach 100 kb.
We demonstrate its feasibility for efficient analysis
of single-copy genes within a large and complex gen-
ome by assaying 230 kb of the human ADAMTS14-
perforin-paladin gene cluster in four experiments.
The results identify distinct networks of regulatory
domains specific to expression of perforin and its
two neighboring genes.
INTRODUCTION
The physiological transcription of eukaryotic genes hinges
upon regulating chromatin structure. More often than not,
this process depends on distal cis-acting control regions.
Genome-wide studies suggest that the majority of these regu-
latory domains reside beyond 10 kb from sites of transcription
initiation (1), some of which can be located hundreds of kilo-
bases from their cognate promoters (2,3). Using currently
available ‘wet-lab’ methodology, comprehensively identify-
ing the entire suite of regulatory sites that control a given
gene can be daunting.
Interspecies genome alignments to identify conserved non-
coding sequences (CNS) are an efﬁcient strategy to scour large
regions for potential regulatory sites (4,5). These computa-
tional approaches are now quite powerful, owing to recent
expansion of high-quality datasets from the various genome
projects (6,7). As an exclusive tool however, they are not yet
capable of predicting the speciﬁcity and potential regulatory
function of CNS (7,8). Moreover, computational approaches
that only rely on identifying candidate regions based on
genomic sequences which align between species may never-
theless overlook conserved motifs with regulatory function,
such as those conserved epigenetically (9,10). Therefore, tra-
ditional experiments that examine chromatin structure and
epigenetic organization remain fundamental to both augment
computational predictions as well as to independently identify
functional regions.
For more than two decades, the DNase I hypersensitivity
assay (DHA) has been instrumental for discovering regulatory
domains (11). This method maps discrete sites in the genome
where the conformation of chromatin renders its DNA hyper-
sensitivetocleavagebytheendonucleaseDNaseI(12).DNase
I hypersensitive sites (DHSs) have been mapped to most cate-
gories of cis-acting regulatory domains including promoters,
enhancers, silencers, insulators and locus control regions
(13–16). The ubiquitous or, alternatively, lineage and activa-
tion speciﬁc formation of DHSs at these respective regulatory
domains frequently belies their function (17,18). DHSs can
indicate transient remodeling of chromatin as in the case of
transcriptional induction, or stable, epigenetic inheritance of
programmed changes to a locus during differentiation (19).
Characterizing the formation of DHSs remains a basic, albeit
robust strategy to determine the speciﬁcity and potential func-
tion of putative regulatory domains.
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doi:10.1093/nar/gkl006Technical limitations restrictclassical DHAmethodologyto
analysis of genes in  20 kb increments. A long-range
approach to DHA has been reported for analysis of a gene-
ampliﬁed locus (20), but a method capable of detecting DHSs
in single-copy genes of mammalian genomes has not.
Recently, PCR based methods and genome-wide strategies
have been developed as an alternative to map DHSs, though
most still require validation using classical approaches, and
also require automation or high-throughput capabilities,
making them inaccessibleto most labs (1,21,22). Inthis report,
we provide a straightforward approach using ﬁeld inversion
gel electrophoresis (FIGE) and demonstrate the ability to
display authentic DHSs in single-copy genes of the human
genome at ranges near 100 kb. This method is as good or
better than the classical DHA and can be readily introduced
into any conventional molecular biology laboratory. In
essentially four experiments, we assayed 230 kb of the
human perforin locus, a region that includes both of its nearest
neighboring genes. This approach discovered three distinct
networks of DHSs that are likely to coordinate the regulation
of perforin and its neighbors.
METHODS
Cell culture
Jurkat (clone E6-1) is a cell-line derived from a T-cell leuke-
mia and was obtained from ATCC. YT is a human NK-like
lymphoma (23). Both YT and Jurkat cells were cultured in
IMDM supplemented with 10% heat inactivated fetal bovine
serum(FBS).HA(10)A isa microcell-hybrid, mouseﬁbroblast
line that carries one copy of a neo
r tagged human chromosome
10 and was obtained from Coriell Cell Repository (item
GM11688) (24). HA(10)A is cultured in DMEM containing
10% FBS, and retains the human chromosome 10 by selection
with 500 mg/ml G418. All culture media was supplemented
with Gentamicin to 50 mg/ml.
Mega-DNase I hypersensitivity analysis (MDHA)
Cell lysis and nuclei isolation. Exponentially growing
lymphocyte cultures were harvested at room temperature,
then washed and concentrated in ice-cold Ca
2+/Mg
2+ free
phosphate-buffered saline (PBS) before adjusting to
2 · 10
7 cells/ml in PBS. Cells were lysed on ice for 10 min
by adding 4 vol of lysis buffer [12.5 mM Tris, pH 7.4, 45 mM
KCl, 6.25 mM MgCl2, 375 mM sucrose and 0.125% nonidet
P-40, supplemented with one complete (EDTA free) protease
inhibitorcocktail(Roche)/50ml]to1volofcells.Forﬁbroblast
cultures, cells were detached by trypsinization, harvested and
washed in PBS, although after the ﬁnal wash they were
re-suspended as 8 · 10
6/ml in ﬁbroblast lysis buffer [12.5
mMTris,pH7.4,5mMKCl,0.1mMsperminetetrahydrochlo-
ride, 0.25 mM spermidine, 175 mM sucrose, supplemented
with one complete (EDTA free) protease inhibitor cocktail
tablet (Roche)/50 ml lysis buffer] and equilibrated on ice for
10 min. These cells were then lysed by adding 0.02 vol of 10%
nonidet P-40, gently vortexing and inverting tubes three times
to mix followed by an additional 5 min on ice. Nuclei were
pelleted at 500 · g for 7 min (lymphocytes), or 1000 · g for
5 min (ﬁbroblasts), in a pre-cooled swinging bucket rotor at
4 C. Nuclei from both cell types were gently re-suspended in
one-tenth of the original lysis volume using nuclei wash buffer
[10 mM Tris, pH 7.4, 60 mM KCl, 15 mM NaCl, 5 mM MgCl2
and 300 mM sucrose] before pooling pellets 2:1 and adjusting
volumes to half the original lysis volume using nuclei wash
buffer; nuclei were pelleted again as above. Supernatants were
completely aspirated and the pellets were re-suspended in
nuclear washbufferand adjustedto2.5 · 10
8nuclei/mlonice.
DNaseI treatement and encapsulation in agarose. A DNase I
cocktail (2· relative to DNase I, CaCl2 and BSA) was pre-
pared on ice by supplementing nuclei wash buffer to 2 mM
CaCl2, 100 mg/ml BSA and DNase I (Roche) to 800 U/ml.
The DNase I was titrated by 2-fold serial dilution in the
same buffer without DNase I. Nuclei were treated on a
timed schedule. One volume of nuclei (2.5 · 10
8/ml) in a
1.5 ml microfuge tube and one DNase I concentration from
the titration were each placed at room temperature for
4 min to equilibrate. Then, 1 vol of the DNase I cocktail
was added to 1 vol of nuclei and digestions proceeded for
4 min at room temperature before being stopped by addition
of 0.5 vol of ice-cold 5· stop buffer (nuclei wash buffer
supplemented to 50 mM EDTA) and placing on ice. Nuclei
were embedded in 1% agarose (ﬁnal concentration) by addi-
tion of 2.5 vol of 2% low-melting (BioRad) point agarose
dissolved in nuclei wash buffer supplemented with 10 mM
EDTA and maintained at 50 C. Nuclei in molten agarose
were gently mixed and immediately dispensed into 75 ml
disposable plug molds (BioRad). The embedded nuclei
were cooled at 4 C 15–20 min before being solubilized to
purify genomic DNA.
Purification and restriction enzyme digestion of genomic
DNA in agarose. Embedded nuclei were solubilized with
stripping buffer [100 mM EDTA, 1% Sodium Laroyl
Sarcosine, 0.2% Sodium Deoxycholate and 1 mg/ml protien-
ase K (Roche)], by using a 10:1 (v/v) ratio of buffer to agarose
block at 50 C, overnight, with gentle rocking and treating
two times. Blocks were then washed ﬁve times, 45 min
each wash, using a 10:1 ratio (v/v) wash buffer (50 mM
EDTA, 20 mM Tris, pH 8.0) to agarose block, at 4 C with
vigorous shaking. The second wash contained 1 mM phenyl-
methylsulfonyl ﬂuoride. Agarose embedded DNA was stored
under a residual volume of wash buffer at 4 C. For restriction
enzyme digestion, agarose blocks were washed 2 · 30 min in
TE (1 mM EDTA) to reduce EDTA from wash buffer,
followed by two sequential 30 min equilibrations at 4 C
using >10 vol (relative to agarose blocks) excess of the
appropriate restriction enzyme buffers. The equilibration buf-
fer was replaced with 4 vol of the appropriate restriction
enzyme cocktail [Pac I (NEB) 90 U/ 4 · 10
6 genomes]
and digestions proceeded for 16 h at 37 C. Reactions were
quenched by removing cocktails and washing each plug
with ice-cold TE, followed by equilibration in 0.5· TBE
running buffer at 4 C without motion. One-half agarose
block ( 37 mlo f5· 10
7 nuclei/ml) was loaded per lane
of 1% pulse ﬁeld certiﬁed agarose (BioRad) gels prepared
in 0.5· TBE and blocks were sealed with 1% low-melting
point agarose also prepared in 0.5· TBE.
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and mapping DHSs
FIGE analysis was performed with a FIGE mapper (BioRad).
The FIGE system is commercially available as part of the
CHEF mapper XA system (BioRad). All FIGE mapper pro-
grams used linear shaped ramps for switch times, a forward
voltage of 180 V, a reverse voltage of 120 V and were run in
re-circulated 0.5· TBE maintained at 14 C.
Following electrophoresis, gels were stained for 40 min in
0.5 mg/ml ethidium bromide in autoclaved water at 4 C with
constant agitation. The gels were photographed under prepara-
tive UV light and DNA was nicked using 70 mJ of UV irra-
diation before being blotted to nylon membranes (Hybond N+)
in alkali (0.4 M NaOH, 1.5 M NaCl) using a capillary transfer
(turboblotter Schleicher&Schuell) by transferring one liter of
buffer through membranes. Membranes were then neutralized
for 5 min in 0.5 M Tris, pH 7.0, and rinsed in 2· SSC before
storing or hybridization.
To map the position of DHSs in the locus, best-ﬁt curves
were generated by manual measurements of the migration
distances of DNA size standards during each FIGE analysis;
gel-to-gel variation in resolution between independent runs of
identical FIGE programs was extremely low (data not shown).
The location of DHSs were determined by measuring the
migration distance of each DNase I dependent sub-germline
bandafterSouthernanalysisandcomputinganaverage fromat
least two independent experiments; bands separated by at least
1 mm were considered distinct. Based on the equation for the
best-ﬁt curve describing the resolution of each FIGE analysis,
experimental fragment sizes were calculated using their
respective average migration distance. For each region
analyzed, the experimentally determined size of the intact
germline fragment was normalized to its known length
based on sequence information (25,26). The sizes of sub-
germline DNase I dependent fragments were standardized
accordingly and the locations of DHSs were expressed relative
to perforin transcription initiation (set to +1) in the human
genome (GenBank accession no. AL355344) (27). The differ-
ence in mapping the same DHS, in different nuclei prepara-
tions from the same cells, was calculated as a percentage
relative to the size of the germline fragment in which it
was mapped to quantify variability: ±%variability ¼ [max
difference in DHS fragments between independent experi-
ments (bp)/germline fragment (bp)] · 50.
Northern and Southern blot analysis
Northern and Southern hybridizations were performed in glass
bottles using a rotisserie oven. Blots were washed in 2· SSC
followed by pre-hydridization using 0.5 ml hybridization
solution (Clonetech ExpressHyb) /10 cm
2 membrane, for
30–60 min at 68 C (Southern) to 70 C (Northern). An
equal volume of hybridization solution containing 1 ng/ml
of TCA precipitable probe was used to replace the pre-
hybridization solution and blots were hybridized for 12 h at
the same temperature as the pre-hybridizations. Blots were
washed with 10 ml wash buffer/10 cm
2 blot, four times at
room temperature in 2· SSC–0.1%SDS for 10 min, one
time in 0.5· SSC–0.1%SDS at 60 C for 20 min, and ﬁnally
at60 Cfor20 min in0.1·SSC–0.1%SDS.Blotswere exposed
to Kodack, BioMax MS ﬁlm using HE intensity screens at
 80 C, or to screens for phosphorimaging and analysis with
the ImageQuant 2.0 software. All conventional probes were
gel-puriﬁed restriction fragments labeled with [a-
32P]dCTP
by the random priming method, puriﬁed by size exclusion
chromatography and quantiﬁed by TCA precipitation.
Probes for MDHA and Northern analysis
Probes for MDHA analysis were either cloned fragments, or
synthetic oligonucleotides. Probes were located within  1k b
of each restriction site used in MDHA analysis and were from
 600 to 1200 bp (cloned fragments) or 30–40 bp (oligos).
Sequences for all probes were selected computationally for the
absence of repetitive elements using RepeatMasker Open-3.0
(http://www.repeatmasker.org) and signiﬁcant similarity to
other sequences (BlastN NCBI) before testing empirically
for single-copy speciﬁcity in genomic Southern analysis.
Oligonucleotides were selected using OLIGO 2.0 software,
comprised sequences of  50% GC content, predicted melting
temperature (Tm) ¼ 65–75 C and were predicted to not form
dimers more stable than  5.0 kcal/mol, or secondary struc-
tures more stable than 2.0 kcal/mol (100 mM salt and 1.0 pM
oligo). Oligonucleotide probes were typically hybridized at
12.5 C below their predicted Tm according the manufacturer’s
suggestions(3DNA—Genishpere;IDTTechnologies) (28,29).
Oligonucleotide probes used to analyze the four Pac I
fragments (78, 39, 26 and 87 kb) were 30 78 kb-ACC-
AGGTGCTAGTAATCATAGAGAGGGCTACAAAGACA-
CA, 50 39 kb-CTGAAGCAAATGA-GGGGCAAGAAGT-
CAATCTGGTAAAAGG, 30 39 kb-ACAAGACCTGAGAC-
AAACTGGG-AGAAAGAACTGACTGTAT, 50 26 kb-GG-
CGACCTCAAATGTTAAGGCAGGAATGGGGA-AATG-
GATA, 30 26 kb-ACCTGAGGGGAAGTCTCTCGTTCT
GGAAGTATCGCAGTTA, 50 87 kb-GTCATAATAGGA-
GAGACGACAGGATCTTCCAGCCCCAACA.
Cloned fragments for probes were excised directly from
genomic clones, or were cloned after PCR of human genomic
DNA with the following primers: 50 end of the PacI 79 kb
fragment (F-ACA-AACGCTCCAGCAAACACTCAT, R-
CCTCCTGTGGTTCCAGAATGTC-AC), the 30 end of the
PacI 79 kb fragment is a PstI–PacI fragment; the 50 end of
the Pac I 39 kb fragment is a Pac I–Pst I fragment, the 50 end of
the Pac I 26 kb fragment (F-GCTTAGATGCC-GTC-
ATTTAGTTCA, R-GACCCCTTTCCTATTGATTTGTTA),
the 30 end of the Pac I 26 kb fragment (F-CCTTGACTC-
AACCTTGCAGACACT, R-TGAGGGAAAGATGTTGGC-
TTCA-G), the 50 end of the Pac I 87 kb fragment (F-GG-
GCTCCTCAGCAAACACGACAA, R-CCCT-ACCACCCC-
TTCCCTCTAATG). Probes for Northern analysis were an
NcoI–BamHI human perforin cDNA fragment, a 2.2 kb
BamHI ADAMTS-14 cDNA (transcript A) fragment (30),
and a 1.4 kb PstI fragment from the paladin cDNA (GenBank
BC040163).
FIGE
program
Separation (kb) Switch times (s)
forward (F) and reverse (R)
Run time (h)
P1 1–30 0.1–0.9 (F), 0.1–0.9 (R) 15
P2 1–60 0.2–1.2 (F), 0.2–1.2 (R) 17.5
P3 1 to >60 0.1–3.5 (F), 0.1–3.5 (R) 18
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Premise and development of MDHA
The manipulation of DNA in solution and standard agarose gel
electrophoresis limits the range at which conventional DHA
methodology can display DHSs. Mechanical forces during
pipeting and the organic extractions or chromatography typi-
cally used to purify genomic DNA from DNase I treated nuclei
causes random breaks in DNA. This ultimately limits the
maximum size of fragments that can be analyzed and also
increases background. Moreover, DNA molecules in excess
of  20 kb cannot be systematically resolved using conven-
tional gel electrophoresis conditions. We therefore incorpo-
rated several straightforward adaptations to overcome these
limitations in order to establish the MDHA method (Figure 1).
Nuclei for MDHA are isolated and treated with DNase I simi-
lar to existing assays. However, to prevent shearing forces
from manipulation of DNA in solution, DNase I treated nuclei
were directly embedded in low-melting point agarose. Both
puriﬁcation of genomic DNA and its subsequent digestion
with restriction enzymes were performed in the context of
the agarose blocks. To generate large restriction fragments
for analysis, 8 bp cutting enzymes were used. These fragments
were resolved using FIGE, a method of pulsed ﬁeld gel
electrophoresis that facilitates separation of DNA molecules
in size from 1 to 10
3 kb (31). Based on previous reports
(32,33), conditions for UV nicking of DNA and capillary
blotting were empirically determined for MDHA (data not
shown) to ensure efﬁcient transfer of the large DNA from
FIGE gels and its optimal hybridization during Southern anal-
ysis. Finally, two approaches for design and application of
probes for Southern hybridization were examined. The ﬁrst
were oligonucleotides (30–40 bp) directly labeled by radioac-
tive tailing with
32P (28), or those linked to multivalent
scaffolds (3DNA dendrimer molecules) labeled with alkaline
phosphotase (29). These strategies were compared with
conventional DNA probes excised from genomic clones
that were labeled with
32P by random priming (34).
We initially validated the MDHA protocol by assaying
known DHSs. To that end, the previously characterized
intergenic region between the human IL-3 and GM-CSF
genes was analyzed in two transformed cell-lines, the helper
T-cell line Jurkat and the natural killer (NK)-like line, YT. The
IL-3/GM-CSF intergenic region contains three constitutive
DHSs that form in most cell types (35) (Figure 2a). Southern
blots generated by the MDHA protocol were hybridized with
3DNA oligonucleotide probes and detected the appearance of
three fragments in response to increasing concentrations of
DNase I (Figure 2b). The DHSs formed at comparable
DNase I concentrations in nuclei preparations from both the
Jurkat and YT cells. The size of each DNase I dependent band
corresponded to the location of the three previously reported
DHSs between the IL-3 and GM-CSF genes. Thus, the MDHA
approachdetectsDHSsinamannersimilartoexistingDHA.Of
note, these experiments were accomplished with a  40 bp
oligonucleotide probe under non-radioactive conditions,
indicating it is possible to detect DHSs of single-copy genes
without the need for cloning to generate conventional probes.
MDHA of 230 kb the perforin locus at human 10q21–22
Previously, we expended signiﬁcant effort using transgenic
methods to identify the essential regulatory regions that con-
trol perforin, a gene that is required for a form of cytolysis
mediated by specialized immune cells known as cytotoxic
lymphocytes. However, multiple transgenes that spanned
45 kb of the human perforin locus were not expressed
physiologically in these cell types (36,37). Similarly, analysis
Figure 1. Comparison of conventional DHA versus MDHA. The classical
DHA method was modified as follows: immediately following DNase I treat-
ment, nuclei were embedded in low-melting point agarose. The DNA remains
protected in the agarose for all subsequent manipulations, including digestion
with rare-cleaving restriction enzymes. Finally, the DNA, containing substan-
tiallylargergenomicfragmentsthanpreviouslyexistingDHAisfractionatedby
FIGE and analyzed Southern blot analysis.
Figure 2. MDHA of known DHSs in the IL-3/GM-CSF intergenic region. (a)
Schematics of the IL-3/GM-CSF locus and the location of the three previously
establishedintergenic DHSs. Horizontal arrows indicate the IL-3and GM-CSF
genes, and vertical arrows show the relative position of the known DHSs. A
HindIII restriction fragment (H) was analyzed in (b) using the indicated probe.
(b)MDHAanalysis.NucleiofJurkatandYTcellsweretreatedwithincreasing
concentrations of DNase I (wedges above blots) and encapsulated into agarose
blocks. The blocks were deproteinized, treated with HindIII and the DNA was
fractionatedbyFIGE.Theshownautoradsrepresenthybridizationswitha40bp
3DNAoligonucleotideprobethatwas conjugated to alkalinephosphotase.The
germlineHindIIIfragment(H)andthethreeDNaseIdependentfragments(I,II
and III) correspond to the schematics shown in (a).
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provide signiﬁcant additional insight as to the essential regu-
latory elements governing the physiologically high expression
of perforin in cytotoxic lymphocytes (38,39). We therefore
presumed additional missing domains were located in far dis-
tal regions of the locus. MDHA was developed speciﬁcally to
identify these potential domains. Encouraged by our prelimi-
nary analysis of the IL-3/GM-CSF locus, we turned our focus
to the perforin gene located on human 10q21–22 (40).
Perforin is simply organized in three exons that span  6k b
(27)andispositioned betweentwoapparentlyunrelated genes,
ADAMTS-14 (GenBank accession no. NM_139155) and
paladin (GenBank accession no. NM_014431). Transcription
of ADAMTS-14 (30) initiates  70 kb upstream of perforin,
while transcription of paladin initiates  124 kb downstream
(Figure 3a) (GenBank NT_008583) (41). ADAMTS-14 codes
for a metalloprotease that is expressed in ﬁbroblasts and
connective tissue (30). Paladin codes for a potential tyrosine
phosphatase with unknown function and is broadly expressed
(42). In contrast, perforin codes for an effector molecule of the
immunesystem thatisexpressedincytotoxiclymphocytes and
deployed from these cells to lyse infected or malignant host
cells (43,44). The perforin gene is constitutively expressed at
high levels in NK cells (45) but typically is not expressed by
non-cytotoxic, helper CD4+ T-cells (46). Therefore, we used
MDHA to analyze the long-range chromatin structure of the
perforin gene and its closest neighboring genes in YT cells
(cytotoxic, NK-like cell-line) (23), Jurkat cells (non-cytotoxic
helper T-cell line) (47) and HA(10)A cells (non-lymphoid
ﬁbroblast cell-line) (24).
A total of 230 kb was analyzed in four large restriction
fragments (79, 39, 26 and 87 kb) (Figure 3a). The experiments
assayed nuclei from at least two independent nuclei prepara-
tions for each cell-type and the entire region was mapped at
least twice, using probes derived from restriction fragments
labeled radioactively by random priming (Figure 3b), as well
as, oligonucleotides linked to 3DNA molecules labeled with
alkaline phosphatase (data not shown). Both approaches
yielded analogous results, however, hybridizations with the
radioactively labeled probes derived from cloned restriction
fragments consistently resulted in less background and, con-
sequently, improved sensitivity. The presence versus absence
of each DHS was determined qualitatively by comparing
autorads side-by-side and the locations of DHSs in the
locus were mapped based on best-ﬁt curves describing each
FIGE separation (for details on mapping see Methods).
MDHA mapped 13 DHSs in Jurkat cells (Figure 3b, left
panels). The majority of these sites were located across
paladin and its intergenic region with perforin. Only two
DHSs were detected in Jurkat cells across nearly 95 kb of
perforin and its upstream ﬂank. MDHA of YT cells mapped
18 DHSs (Figure 3b, middle panels). Unlike Jurkat cells, the
majority of these DHSs were located over and upstream of
perforin. Finally, in HA(10)A cells, 12 DHSs were detected.
They mapped almost exclusively to regions overlapping the
ADAMTS-14 and paladin genes (Figure 3b, right panels). The
maximum variability in mapping any one DHS was ±7.7%,
which translates to mapping the same DHSs within ±800 bp at
a range of 10 kb (see Methods); precision comparable to
conventional DHA. The largest variability correlated with
DHSs that resolved in regions of gels where migration of
DNA was the least linear; the migration rate of DNA during
FIGE analysis is not linear across all molecule sizes when
ramping between switch times is linear. However, this is usu-
ally conﬁned to a small region of the gel, thus the majority of
all DHSs were mapped to within <1.0% of the same position
between independent experiments. We concluded MDHA
reproducibly mapped genuine DHSs from single-copy genes
in the human genome at ranges up to 87 kb.
DHSs detected by MDHA display known and unknown
regulatory regions
Only one report has previously mapped DHSs of human
perforin, and this centered on a region 1.4 kb upstream and
1.3 kb downstream of transcription initiation. Two areas of
DHSs were identiﬁed, one near  0.2 kb and a second cluster
spanning  0.8 to  1.0 kb; they are present in YT cells and
cytotoxic T-cells as well as helper T-cells, but are absent in
ﬁbroblasts (39).Two DHSs are present in analogous regions of
the mouse locus in perforin expressing cells (38). Similarly,
MDHA mapped two broad DHSs in YT cells, one centered at
 2.4 kb and a second area at + 2.6 kb. We presume the ﬁrst
collectively comprises the previously identiﬁed DHSs near the
promoter and perhaps an additional DHS near conserved
sequences spanning  1.7 to  1.9 kb (Table 1). The second
DHS maps to perforin’s second intron, a region wherein anal-
ysis has not been reported in the human locus, but is near a
CNS and an analogous region in mouse perforin where two
DHSs have been reported (38). Thus, MDHA results were
consistent with the prior studies. Nevertheless, given the
focused interval examined in the previous studies, an entirely
systematic comparison with the long-range analysis by
MDHA is difﬁcult.
Recent genome scale analysis of DHSs in human helper T-
cells based on sequencing cloned fragments resulting from
DNase I cleavage of nuclear DNA has been reported (22).
We compared DNase I cutting events in the perforin locus
that were identiﬁed by this strategy (http://research.nhgri.nih.
gov/DNaseHS), to the location of those we mapped by MDHA
(Table 1 and Figure 4b). In the genome-wide assay, separate
validation indicates conﬁdence in predicting a genuine DHS
depends on identifying multiple tags within 500 bp of each
other (22). Four sites in the perforin locus were identiﬁed with
at least two tags clustered within 500 bp. The core size of a
nuclease sensitive domain in a DHS is on the order of 150–
200 bp, though the extent of nuclease sensitivity may extend
beyond this core (21). Therefore, we also considered
sequenced tags in the perforin locus that clustered within
1000 bp, which revealed two additional sites, that were also
proximal to the predicted map location of DHSs identiﬁed by
MDHA. Thus results from the MDHA analysis validate those
from a genome-wide approach, but also identiﬁed additional
genuine DHSs not detected by the whole genome strategy—at
least in context of the number of tags sequenced, and cells
assayed, in that analysis.
Regulatory elements are found in CNSs, and consequently
they often map in or near DHSs (7). We therefore compared
the location of non-coding sequences conserved between
humans and mice with the locations of DHSs that were
identiﬁed by MDHA (Table 1). Most DHSs mapped within
 1000 bp of CNSs identiﬁed by VISTA analysis (48). In
PAGE 5 OF 11 Nucleic Acids Research, 2006, Vol. 34, No. 4 e34Figure 3. MDHA of the ADAMTS14, perforin and paladin loci. (a) Map detailing the essential components used in the MDHA analysis. A total of 230 kb was
analyzed in four experiments. The exons and transcriptional orientation of perforin and its two neighboring genes are indicated in relation to the PacI restriction
fragments(P)thatwereanalyzed.ThesizeofPacIfragmentsareshownbelowthemapinadditiontothelocationofthehybridizationprobes(numberedsquares)that
werehybridizedtotheSouthernblotsin(b).(b)MDHAofperforinanditsflankinggenesinJurkatandYTandHA(10)Acell-lines.TheSouthernblotsarenumbered
accordingtothehybridizationprobesdenotedin(a).DHSsareindicatedwitharrowsandtheircomputedmaplocationsarereportedrelativetoperforintranscription
initiation (set as +1); the variability in mapping the same DHSs in independent experiments is indicated in parentheses (see Methods). Those shown in bold were
interpreted to be the same DHSs in all three cell-lines, based on qualitative side-by-side comparisons following autoradiography. The autorads shown represent
multiple experiments (at least two independent nuclei preparations) as well as hybridizations with different probes and labeling techniques (shown are images
obtainedwithrandomprimedlabeledradioactiveprobes;imagesobtainedfromnon-radioactiveoligonucleotideprobesandprobeshybridizingtothereciprocalends
of the PacI restriction fragements are not shown).
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of human–mouse conservation were nevertheless mapped near
to sequences that were conserved between humans and other
species, such as the dog (Figure 4b) (49). The predicted map
location of DHSs identiﬁed by MDHA in proximity to CNSs
didnotpreciselyoverlapallCNS,butwasnotsurprising.There
is not necessarily a strict correlation between the peaks in
sequence conservation and the exact position of an associated
DHS. DHS has also been identiﬁed in regions that are not
considered CNS (7,21). Therefore, although the resolution
of each FIGE program does not map DHSs to the base pair,
MDHA mapped DHSs with sufﬁcient precision to enumerate
particular CNSs that are likely to be functionally relevant
among all conserved regions. It also clearly identiﬁed addi-
tional regions that do not share signiﬁcant nucleotide identity
between species but that nevertheless may be functional.
DHSs detected by MDHA correlate with
gene expression
To determine the speciﬁcity and infer the potential role of the
distinct patterns of DHSs in Jurkat, YT and HA(10)A cells, the
mRNA expression of ADAMTS14, perforin and paladin
was determined by Northern blot analysis (Figure 4a).
ADAMTS-14 transcripts were expressed in both YT cells
and in HA(10)A cells, but were undetectable in Jurkat cells
(Figure 4a). This correlated with the DHSs pattern over
ADAMTS-14 in these three cell types. Three of the same
DHSs, one which maps to the ADAMTS-14 promoter region,
were present in both HA(10)A and YT cells but were not
formed in Jurkat cells (Figures 3 and 4b), suggesting these
DHSs may be positive regulatory domains speciﬁc to
ADAMTS-14 expression.
Perforin mRNA was undetectable in HA(10)A cells but was
expressed in YT cells and Jurkat cells (Figure 4a). Quantita-
tively, the YT cells expressed >100-fold more perforin mRNA
than what was detected in Jurkat cells. In fact, the abundance
of perforin mRNA in Jurkat cells corresponds to only 5% of
what is physiological, as compared to primary human cyto-
toxic lymphocytes (M. E. Pipkin and M. G. Lichtenheld,
unpublished data). However, Jurkat and YT cells shared a
similar pattern of DHSs in regions proximal to the perforin
gene, and in the intergenic region between it and paladin
(Figure 4b). This included DHSs near the perforin promoter
Table 1. DHSs detected by MDHA align with CNS and sequences identified in genome-wide DHSs analysis
Probes MDHA Ref. (48) human/mouse Ref. (22) CD4+ T
Jurkat YT HA(10)A CNS DHS cluster
DHS DHS DHS
*  73251 (1.0%)  75992 (2.5%)  76927,  77026
 69460,  69677
*  70420 (0.2%)  70013 (2.5%)  69113,  69211
 68875,  68994
 61970,  62368  63080,  63149
*  63495 (0.1%)  61039 (1.0%)  60964,  61063
1  57973 (0.5%)  58301 (0.3%)  57499 (0.2%)  54438,  54585
 50416,  50631
*
*
*
*  9453 (2.2%) * *
2  3579 (4.3%)  2380 (2.9%) *  1753,  1855
 6,  169
+1469 (7.7%) +2553 (5.6%) * +2761, +2646
+11036 (7.2%) +11077 (3.4%) * +12873, +12707
+26251 (0.2%) +26216 (0.3%) +27174 (1.0%) * +23078, +22471
+37472 +37881 * * +38380, +37210
3 +40624 (0.1%) * * +40263, +40158
+41789, +41660
+43329 (0.0%) +43320 (0.6%) +43202 (0.5%) +43233, +43117
* +45032 * *
* +46797 * +47211, +47056
+47442, +47303
+53754 (0.1%) +53370 (0.4%) +52027 (0.1%) * +57944, +57216
+79506 (5.2%) +81751 (3.6%) +77547 (0.0%) *
4 +86197 (3.4%) * +95359 (0.0%) +94170, +94011
+111156 (1.9%) * +109609 (0.0%) +111370, +111212 +109129, +108916
+124462 (0.1%) * +123859 (0.0%) +124292, +124162 +125115, +124860
+125575, +125447
ThetablereportsthepredictedmaplocationofDHSsidentifiedbyMDHA,nearbysequencesconservedbetweenhumansandmice(CNS),andsequencetagclusters
identified by genome-wide recovery of DHSs, relative to the transcription initiation site of perforin (+1). DHSs identified by MDHA are shown with the difference
(±percentage of germline band) in predicted map locations between independent experiments within the same cell-lines. Those shown in bold were qualitatively
interpreted to be the same DHSs in side-by-side comparison following Southernanalysis in all three cell-lines analyzed. Non-coding sequences conserved between
humansandmice(70%sequenceidentityacross100bp)areindicatedandwereretrievedviatheVISTAbrowser(http://pipeline.lbl.gov/cgi-bin/gateway2),usingthe
humanMay2004genome,sequencesfromchr10:71900000–72130000,alignedwiththe mouseMay2004genome(48).Sequencetagsare thoseclusteredwithin
500 bp (bold), or 1000 bp (http://research.nhgri.nih.gov/DnaseHS) (22).
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was similar to the DHSs identiﬁed by traditional DHA in
primary human helper T-cells and YT cells (39). However,
perforin’s extended upstream region was virtually devoid of
DHSs in Jurkat cells, while YT cells demonstrated additional
DHSs in the extended 50 ﬂank. Several of these DHSs were
closer to the ADAMTS-14 gene, yet these DHSs were not
present in HA(10)A cells which transcribe ADAMTS-14, but
not perforin. Therefore, these distal DHSs may be positive
regulatory domains speciﬁc to perforin.
Finally, paladin mRNA was expressed in HA(10)A and
Jurkat cells, but was not expressed in YT cells (Figure 4a).
HA(10)A and Jurkat cells displayed a nearly identical DHS
pattern across the paladin gene, including a DHS that mapped
near its putative transcription initiation site (Figure 4b). In
contrast, YT cells did not form this DHS and also lacked
Figure4.GeneexpressionandDHSformationat10q21-22.(a)NorthernblotanalysisofmRNAexpressionfromperforinanditsneighboringgenesinJurkat,YTand
HA(10)A cells. For Northern analysis, total RNA was extracted from cells using TRIZOL (Invitrogen) and 20 mg of total RNA was electrophoresed through
formaldehyde agarose gels and blotted to nylon membranes. The blots were sequentially hybridized with cDNA probes from each of the indicated genes. Ethidium
bromidestainingofthemembranesfollowingtransfer(RNA)isshownforloadingconsistency.(b)SchematicsummaryofDHSsidentifiedbyMDHAinJurkat,YT
andHA(10)Acells.TheDHSsidentifiedbyMDHA(verticalarrows)andsequencetagsclusteredwithin500bp(closedboxes;asterisksdenotethoseclusteredwithin
1kb)fromgenome-widerecoveryofDHSswereplacedonamapalignedwiththelocusandaconservationplotfromtheUCSCgenomebrowser(chr10:71900000–
72130000;http://genome.ucsc.edu/,May2004release)(22,41).Thelikelihoodofconservationinthehumangenomeandtheindividualpair-wisealignmentsfrom
themouseanddoggenomesareshownbelowtheconservationplot.Thelocationsofgenes,theirexons(verticalbars)andtheirtranscriptionalorientation(horizontal
arrows) are indicated.
e34 Nucleic Acids Research, 2006, Vol. 34, No. 4 PAGE 8 OF 11the remaining DHSs over the 50 portion of the paladin gene
that were present in both the HA(10)A and Jurkat cells
(Figure 4b). This is consistent with the conclusion that
DHSs downstream of the DHS located near +80 kb, as
being positive regulatory domains speciﬁc to paladin.
DISCUSSION
In this report, we adapted the classical DHA into an approach
we termed MDHA in order to facilitate the long-range analysis
ofsingle-copy genes inlargeand complex genomes (Figure1).
MDHA reproducibly displayed DHSs from multiple loci in
both conventionally sized regions (Figure 2) as well as in
fragments up to 87 kb (Figure 3b). The MDHA displayed
previously established DHSs from the IL-3/GM-CSF locus
and it discovered new DHSs in the perforin locus. DHSs
from the perforin locus mapped in proximity to CNS regions
and clustered sequence tags identiﬁed in genome-wide
DHSs assays (Table 1). Distinct networks of DHSs identiﬁed
by MDHA correlated with the cell-type restricted expression
of perforin and its neighboring genes (Figure 4). This report
emphasizes that it is practical to detect genuine DHSs in
single-copy genes from large genomes at ranges on the
order of 100 kb. Thus, comprehensive analysis of all regions
of a particular gene or gene cluster, including distal locales,
can be systematically and efﬁciently assayed in a single study.
Advantages and limitations of MDHA
MDHA can analyze 100 kb using similar resources and in a
similar time frame to what is required by traditional
approaches to analyze a 20 kb region; at least a 5-fold
improvement in throughput over classical DHA. An earlier
long-range approach developed to analyze a gene-ampliﬁed
locus in cell-lines, suggests assaying even larger regions may
be feasible (20). All of our experiments were performed on
15 cm gels, which limits the maximum size region that can
be adequately resolved to discriminate distinct DHSs. The
resolution of DHSs depends on the length of the DNA inves-
tigated, the actual location of DNase I cleavage sites, and the
FIGE analysis program used to separate the DNA. Conse-
quently, the resolution of MDHA might be low in certain
cases. In particular, distinguishing neighboring DHSs that
result from narrowly spaced DNase I cutting events located
distal to the probe used in the analysis can be difﬁcult. How-
ever, such DHS clusters can be delineated by displaying the
DHSs from the reciprocal direction using a different probe, or
mapping at higher resolution in the context of smaller restric-
tion fragments. In any case, MDHA is at least informative of
the approximate location of DHSs in large regions and estab-
lishes the basis of more focused studies. Using longer gels we
anticipate to extend the distance that MDHA can analyze in
a single experiment, with improved resolution.
At present, the resolution of MDHA is similar to classical
DHA methods, but does not compare with recently developed
high-throughput methods founded on the DHA concept. Both
a quantitative PCR strategy and genome-wide methods have
been reported for localizing DHSs (1,21,22,50). Both class of
strategies provide at, or near, base pair resolution of DNase I
cutting events. However, the PCR approach would require at
least 1000 optimized primer sets to analyze the same region of
perforin that was assayed by MDHA using only four
hybridization probes. Moreover, reliable prediction of genuine
DHSs by genome-wide approaches relates exponentially upon
the frequency of sequenced tags clustering to a small genomic
interval. Simulations in silico based on the most robust method
estimates that, at a false positive rate of <10%, 4 · 10
6
sequenced tags will only predict 20% of all DHSs in the
human genome (21). The need to compare multiple cell
types, or stimulation conditions, renders these scales unfeasi-
ble for application by the typical bench scientist. Although
MDHA is not sufﬁcient for mapping DHSs to the base pair,
DHSs in the perforin locus that had been predicted by one
genome-wide approach were mapped by MDHA with consid-
erable accuracy, even at very long ranges (Table 1). Therefore,
we conclude that MDHA is sufﬁciently precise to accurately
localize DHSs for further functional studies, although some
cases may warrant additional ﬁne mapping. Importantly, dis-
secting the regulation of a particular gene does not initially
depend upon knowing the location of DHSs to the base pair.
Rather, it is essential to map candidate regulatory sites, within
some quantiﬁable degree of error, around which functional
analyses are designed to ultimately delineate an active module
to its genetic elements. Methods to efﬁciently manipulate
genomic clones propagated in bacterial artiﬁcial chromosome
(BAC) vectors, for transgenes and targeting constructs, are
now well established (51). Thus, to guide those designs,
MDHA will be a practical tool for the molecular biologist
as it can efﬁciently map hundreds of kilobases for authentic
DHSs but does not require high-throughput or automated
systems.
MDHA and a DHSs blueprint of the human
perforin locus
Using MDHA, DHSs that formed in the ADAMTS-14, perforin
and paladin loci have been associated with the differential
expression of each gene in three model cell lines. The cell-
type restricted pattern of expression suggests that expression
from each of the three genes is not co-regulated. Therefore, it
is possible that each locus is organized in a large territory or
chromatin domain subdivided by insulators (52,53). The
organization of DHSs identiﬁed in this study by MDHA is
consistent with that hypothesis. MDHA mapped ﬁve DHSs at,
or near, the same location in all three cell-lines ( 58, +26,
+43, +53 and +80 kb), regardless of ADAMTS-14, perforin and
paladin expression (Figure 4b), which suggests they form
independent of the expression from the three neighboring
genes. This is characteristic of many previously characterized
insulators, which often form more or less ubiquitously among
tissues and do not correlate with expression of nearby genes
(17,54). In contrast, DHSs located upstream of  58 kb were
only present in cells expressing ADAMTS-14. Therefore, it is
conceivable that the DHSs near  58 kb indicate one boundary
between territories that control expression of ADAMTS-14 and
perforin. Similarly, DHSs downstream of +80 kb were only
present in cells expressing paladin, potentially suggesting it as
a boundary between the paladin and perforin territory.
It is likely that most if not all regulatory domains required
for physiological perforin expression are located between the
DHSs mapped at  58 and +80 kb. Between these DHSs,
MDHA mapped 10 additional DHSs in cells that express
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from cells that do not express perforin [HA(10)A]. This sug-
gests they comprise positive regulatory regions (i.e. enhancers
and a locus control region) important for perforin expression.
Of these DHSs, ﬁve were also present in the perforin-low cells
(Jurkat) (Figure 4b), implying that these sites are some, but
perhaps not all regulatory domains necessary for the physio-
logically high levels of perforin expression in cytotoxic lym-
phocytes. This result is consistent with prior studies that
demonstrated sequences of perforin spanning  21 to + 24
kb collectively mediate tissue speciﬁc and inducible perforin
expression, but do not confer copy number dependent or
physiological amounts of expression to perforin transgenes
in cytotoxic lymphocytes from transgenic mice (37). Since
results here show that several DHSs found only in YT cells
[i.e. not in Jurkat or HA(10)A cells] were located outside the
regions assayed by the transgenes, several potentially key
regulatory domains were not included. Two of these DHSs
near  49 to  44 kb migrated in a portion of the FIGE gel
where small differences in migration corresponded to large
differences in fragment sizes, and thus may represent multiple
closelyspacedDHSs.Anadditionalexperiment toimprovethe
resolution of this region is underway. Nevertheless, we antici-
pate that the long-range capability of MDHA has discovered
the potentially instrumental regulatory regions that had eluded
several earlier transgenic studies of the perforin locus. There-
fore, in general, we propose creating a DHS blueprint of a
locus by mapping with MDHA is the foundation for more
rational design of transgenic experiments using large genomic
clones from the widely available BAC and PAC resources.
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